Injective (INJ) is currently priced at $3.57, reflecting a 24-hour decline of 2.95%. The daily price range has been relatively tight, with a high of $3.68 and a low of $3.45, indicating a lack of volatility in the short term.

Trading volume stands at approximately 65.5 million, which is significant at 18.37% of the market cap, suggesting active trading interest. However, the price has seen a negative trend, with a 7-day price change of -19.34% and a 14-day change of -23.72%, indicating bearish sentiment over the recent weeks.

Technical indicators show mixed signals; the hourly moving averages are slightly bullish, with the 8 SMA at $3.56 showing a minor increase of 0.21%. However, the longer-term moving averages, particularly the 144 SMA at $4.05, reflect a downward trend of 11.82%, which is concerning for longer-term holders.

The Relative Strength Index (RSI) shows a short-term strength at 62, suggesting potential upward momentum in the immediate term. Conversely, the 7-day RSI at 39 indicates that INJ is nearing oversold conditions, which could imply a potential rebound if buying interest materializes.

With the all-time high of $52.62 set earlier this year, the current price represents a significant drop, highlighting a drastic decrease in market confidence. The persistent negative price changes over the past month further underscore the prevailing bearish trend.

Considering the current data, INJ shows signs of short-term resilience but remains under pressure in the longer term. Therefore, the rating is a Hold; while there may be short-term trading opportunities, the overall bearish trend and historical performance suggest caution before considering a buy.